Skip to main content

Novo Nordisk Signs ActiveSight for Protein Crystallography

NEW YORK, Jan. 23 (GenomeWeb News) - ActiveSight has signed a deal with Novo Nordisk to provide protein crystallography, the company announced today.


Terms of the agreement were not disclosed.


ActiveSight is a division of Rigaku that features a portfolio of drug targets for co-crystallography.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.